Q2 2025 13F Holders as of 6/30/2025
-
Type / Class
-
Equity / Ordinary Shares
-
Shares outstanding
-
130M
-
Number of holders
-
50
-
Total 13F shares, excl. options
-
34.7M
-
Shares change
-
-13.2M
-
Total reported value, excl. options
-
$20.5M
-
Value change
-
-$8.23M
-
Put/Call ratio
-
0
-
Number of buys
-
30
-
Number of sells
-
-49
-
Price
-
$0.59
Significant Holders of PROKIDNEY CORP. - Ordinary Shares (PROK) as of Q2 2025
87 filings reported holding PROK - PROKIDNEY CORP. - Ordinary Shares as of Q2 2025.
PROKIDNEY CORP. - Ordinary Shares (PROK) has 50 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 34.7M shares
of 130M outstanding shares and own 26.73% of the company stock.
Largest 10 shareholders include SUVRETTA CAPITAL MANAGEMENT, LLC (12.3M shares), MORGAN STANLEY (5.99M shares), Bleichroeder LP (2M shares), BlackRock, Inc. (1.76M shares), JPMORGAN CHASE & CO (1.67M shares), VANGUARD GROUP INC (1.57M shares), GEODE CAPITAL MANAGEMENT, LLC (1.01M shares), Brown University (1M shares), Hennion & Walsh Asset Management, Inc. (937K shares), and BANK OF AMERICA CORP /DE/ (846K shares).
This table shows the top 50 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.